BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29
• 30

• Skye Bioscience to Present at H.C. Wainwright 25th Annual Global Investment Conference

  Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye”), a pharmaceutical company developing proprietary medicines that modulate the endocannabinoid system to treat diseases with inflammatory, fibrotic, and metabolic processes

  September 5, 2023

   · 

  3 min read
• Satellos Expands Leadership Team with New CFO Appointment

  Satellos Bioscience Inc. (TSXV: MSCL) (OTCQB: MSCLF) (“Satellos” or the “Company”), a public biotech company developing new small molecule therapeutic approaches to improve the treatment

  September 5, 2023

   · 

  7 min read
• Medexus Strengthens Balance Sheet with US$18 Million Commitment Under Accordion Facility

  Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) today entered into an amendment to the company’s senior secured credit agreement with BMO as agent and lender.

  September 5, 2023

   · 

  4 min read
• NervGen Pharma to Present on Its Drug Candidate NVG-291 and Spinal Cord Injury at the H.C. Wainwright 25th Annual Global Investment Conference

  NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF), a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage

  September 5, 2023

   · 

  5 min read
• Apotex Corp. Launches Brimonidine Tartrate Ophthalmic Solution, 0.1% in the United States

  Apotex Corp. has released its latest ophthalmic product in the United States, announcing today that brimonidine tartrate ophthalmic solution, 0.1% is now available.

  September 5, 2023

   · 

  1 min read
• Biotech Beach

  Arcutis to Present at Upcoming September 2023 Investor Conference

  Arcutis Biotherapeutics, Inc., an early-stage commercial company focused on developing meaningful innovations in immuno-dermatology, announced that Arcutis management will participate in an upcoming investor conference.

  September 5, 2023

   · 

  2 min read
• Biotech Beach

  ResMed Announces Participation in Upcoming Conferences

  ResMed announced its participation in two upcoming conferences.

  September 5, 2023

   · 

  1 min read
• Biotech Bay

  Terns Pharmaceuticals to Participate in Upcoming September 2023 Investor Conferences

  Terns Pharmaceuticals, Inc. announced that members of senior management will be participating in the following upcoming investor conferences in September.

  September 5, 2023

   · 

  1 min read
• Pharm Country

  Delcath Systems to Participate at the H.C. Wainwright 25th Annual Investor Conference on September 12 and 13, 2023

  Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, will participate at the H.C Wainwright 25th Annual Global Investor Conference.

  September 5, 2023

   · 

  1 min read
• Biotech Bay

  PhenomeX Inc. Announces Commencement of Cash Tender Offer by Bruker

  PhenomeX Inc. announced that Bruker Corporation has commenced, through its wholly owned subsidiary, Bird Mergersub Corporation, a cash tender offer to purchase all outstanding shares of common stock of PhenomeX for $1.00 per share.

  September 5, 2023

   · 

  4 min read